Evidence map›Paper›PMID 39446577›Full record

ArticleJournal of the American Society of Nephrology : JASN2025

Improving Processes of Care after Acute Kidney Injury.

L Parker Gregg, David E Leaf

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

L Parker GreggSection of Nephrology, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-5469-367
David E LeafDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0001-7875-090

Funding

Deferoxamine for the Prevention of Acute Kidney InjuryR01DK125786 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI LEAF, DAVID EVAN · 2020 to 2024
$3.5M
Development, Validation, and Harmonization of Methods for Collection and Measurement of NAD+ and Related Metabolites: Application to a Randomized Trial of Patients Undergoing Coronary Artery BypassU01AG089040 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHALENDER BHASIN, David Evan Leaf · 2024 to 2026
$3.4M
Hepcidin-Ferroportin-Iron Axis in Cardiac Surgery-associated Acute Kidney InjuryR01DK126685 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI LEAF, DAVID EVAN · 2022 to 2025
$3.3M
Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKDIK2CX002368 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI GREGG, LUCILE PARKER · 2022 to 2025
–
CSRD VA IK2 CX002368NIA NIH HHS U01 AG089040NIA NIH HHS U01AG089040NIDDK NIH HHS R01 DK125786NIDDK NIH HHS R01DK125786NIDDK NIH HHS R01 DK126685NIDDK NIH HHS R01DK126685US Department of Veterans Affairs CIN13-413US Department of Veterans Affairs IK2CX002368
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39446577
PMCPMC11888948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.